Virology Market to reach a valuation of US$ 3.53 Bn by 2032

Newark, United States, 10/10/2022 / Future Market Insights, Inc. /

[250 Pages Report] Virology, the study of viruses, is an unparalleled branch of life sciences. With immensely high prevalence of diseases such as flu, hepatitis, AIDS, and STDs, the importance of virology is repeatedly highlighted. The global virology market is expected to grow over 2022-2032.

FMI’s research identifies growing infectious diseases as a key force driving the market throughout the forecast period.

Key Drivers: Virology Market

Early in 2016, the WHO officially issued a warning about the possible spread of zika virus to each Western Hemispheric region, as the disease vector Aedes aegypti was found to thrive strong in tropical and sub-tropical climatic conditions. This has been a key driver of market growth throughout 2016.

The virology market is constantly catering to the prevention and cure needs put forth by the healthcare sector; however, several diseases continue to demand R&D of novel applications, driving the growth of virology market. Various treatments and diagnostic processes also employ virology applications, further fuelling the market growth.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1150

Burgeoning applications of virology research in gene therapy, phage therapy, formulation of vaccines, and synthetic biology is another factor fostering the overall growth of the virology market.

Moreover, the field of virology is extending in various forms, including molecular virology, paediatric virology, computational virology, and many more, prompting at increasing research findings throughout the forecast period. Research prospects are high and FMI indicates a continuing need for trained virologists in the near future.

Public awareness programmes conducted worldwide on flu, zika virus, STDs, AIDS, and Ebola virus are also a key factor increasing public awareness and eventually influencing the market.

Key Restraints to Market Growth

Maintaining the quality and safety standards of viral a controlling therapy has been a longstanding challenge, which is anticipated to hamper the market in the forecast period as well. Moreover, stringent approval processes for antiviral drugs is also foreseen to be a restraint to market growth. Another factor identified for affecting the market growth includes resistance toward and side effects of antiviral drugs for new treatment options.

Current Trends in the Virology Field

In 2015, the virology industry was predominantly influenced by ebola, MERS, and hepatitis C viruses. In 2016, zika virus is dominating the research, with better prospects in the near future. Virologists are persistently investigating novel applications for viruses. Currently, an ongoing research is experimenting on the exploitation of viruses for plant production, aiming at the efficient production of high quality, eco-friendly food.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1150

Global Virology Market: Competitive Landscape

By 2017 end, a few important patents are approaching expiry, including Tamiflu, Sustiva, Tenofovir, Combivir, Relenza, and Telbivudine. Following expiry of these blockbuster drugs, the market is estimated to discover a dynamic competitive landscape. The generic competition in the virology market will be at a high pace 2017 onward.

Apart from expiring drugs, the market also has some late stage pipeline drugs, including Inavir, Elvitegravir, Vicriviroc, Rilpivirine, and Rapiacta. These drugs are set to enter the global market, fostering the competition globally.

Regional Outlook: Global Virology Market

North America is the largest virology market led by the U.S., owing to technological advancements such as rapid, portable diagnostics. N. America is expected to retain the top market position over the forecast period as well.

Europe is projected to maintain the position as the second largest market globally. During the forecast period, Europe is anticipated to record the highest CAGR, attributed by enhanced healthcare infrastructure, facilitated access to diagnostics, and growing affordability of diagnostic tests for viral diseases.

Japan is currently a growing virology market, which is estimated to grow at a remarkable CAGR through to 2025. However, APEJ and Africa are expected to witness the most promising growth opportunities during the forecast period. While China will be a leading APEJ market, India will contribute a considerable revenue share to the APEJ virology market.

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1150

Key Players in the Global Virology Market

The notable players identified in the global virology market include GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc., Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche.

Merck and Co. Inc. has several drug candidates in phase 2, including cancer, diabetes, cardiac arrest, and hepatitis C, and some candidates in phase 3, including breast cancer, atherosclerosis, Alzeimer’s, ebola, and HIV. The company also has many other candidates, which are currently under review.

Abivax, a high profile biotech company in Paris, France, has already successfully produced candidates against dengue and chikungunya viruses. The company has a few more candidates against HIV and ebola, currently under development.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, accessories and applications.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Virology Market: Segmentation

Based on product type, the global virology market is segmented into

• Diagnosing Test
• DNA Viruses
• RNA Viruses
• Prions Diagnostic Test
• Other Viral Tests
• Viral Infection Controlling Methods
• Immunoprophylaxis
• Active Prophylaxis (Vaccines)
• Passive Prophylaxis
• Antiviral Chemotherapy
• Virucidal Agents
• Antiviral Agents
• Immunomodulators
• Interferons
• Cytokines

FMI’s research on the global virology market provides a 10-year forecast, segmenting the market on the basis of application, end-use, and region.

Based on application, the global virology market is segmented into

• Skin and Soft Tissue Infections
• Respiratory Tract Infections
• GI Tract Infections
• Urinary Tract Infections
• Eye Infections
• CNS Infections
• Sexually Transmitted Diseases
• Perinatal Infections

According to the end-user, the market is segmented into

• Hospitals
• Clinics
• Laboratories
• Diagnostic Centres
• Blood Banks
• Pharmacies

Explore Other Reports Links From Healthcare Market

Virology Specimen Collection Market : The global Virology Specimen Collection Market size was valued at US$ 5.6 Bn in 2021 and is estimated to experience a negative CAGR of -0.5% during the forecast period of 2022-2032.

Pharmacy Refrigerators Market : The global pharmacy refrigerators market is estimated to be valued US$ 552.3 million in 2022, rising to US$ 1,027 million by 2032 with a CAGR of 5.8 percent during the forecast period.

Immunoassay Market : The global immunoassay market is expected to be worth USD 45.78 billion by 2032, growing at a CAGR of 5% from its current value of USD 29.51 billion in 2022.

The post Virology Market to reach a valuation of US$ 3.53 Bn by 2032 appeared first on Future Market Insights.

Original Source of the original story >> Virology Market to reach a valuation of US$ 3.53 Bn by 2032